Home NDC 68152-102 Fusilev
Product NDC 68152-102
11-digit product format 681520102
Labeler code 68152
Product ID 68152-102_47e3f48c-6c9e-4116-94a7-a08d4ffa4f6f
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name levoleucovorin
Dosage form INJECTION, SOLUTION
Route INTRAVENOUS
Labeler Spectrum Pharmaceuticals, Inc.
Application NDA020140
Marketing category NDA
Marketing start 2011-09-15
Marketing end 0000-00-00
Substance LEVOLEUCOVORIN CALCIUM
Active strength 10 mg/mL
Pharmacologic classes Folate Analog [EPC],Folic Acid [CS]
NDC exclude flag E
Listing certified through 2018-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 39 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Code Status Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 68152-102-02 D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 68152-102-01 D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 68152-102-02 D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 68152-102-01 D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product D Discontinued by firm 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 68152-102-02 D Discontinued by firm 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 68152-102-01 D Discontinued by firm 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product D Discontinued by firm a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 68152-102-02 D Discontinued by firm a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 68152-102-01 D Discontinued by firm a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product D Discontinued by firm cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 68152-102-02 D Discontinued by firm cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 68152-102-01 D Discontinued by firm cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product D Discontinued by firm cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 68152-102-02 D Discontinued by firm cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 68152-102-01 D Discontinued by firm cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product D Discontinued by firm 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 68152-102-02 D Discontinued by firm 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 68152-102-01 D Discontinued by firm 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product D Discontinued by firm ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 68152-102-02 D Discontinued by firm ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 68152-102-01 D Discontinued by firm ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product D Discontinued by firm 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 68152-102-02 D Discontinued by firm 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 68152-102-01 D Discontinued by firm 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product D Discontinued by firm ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 68152-102-02 D Discontinued by firm ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 68152-102-01 D Discontinued by firm ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product D Discontinued by firm 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 68152-102-02 D Discontinued by firm 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 68152-102-01 D Discontinued by firm 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product D Discontinued by firm 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 68152-102-02 D Discontinued by firm 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 68152-102-01 D Discontinued by firm 557ba5c1ecfa…9c80585c8c6e…2019-12-08 06:16 UTC · source 2019-12-05 excluded product product E Excluded after deficient or non-compliant submission was not corrected 110d247fa046…a55b01930146…2019-12-08 06:16 UTC · source 2019-12-05 excluded package package 68152-102-01 E Excluded after deficient or non-compliant submission was not corrected 110d247fa046…a55b01930146…2019-12-08 06:16 UTC · source 2019-12-05 excluded package package 68152-102-02 E Excluded after deficient or non-compliant submission was not corrected 110d247fa046…a55b01930146…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 3 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N020140-001 FUSILEV LEVOLEUCOVORIN CALCIUM EQ 50MG BASE/VIAL POWDER / INTRAVENOUS RLD 2008-03-07 N020140-002 FUSILEV LEVOLEUCOVORIN CALCIUM EQ 175MG BASE/17.5ML (EQ 10MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** SOLUTION / INTRAVENOUS RLD 2011-04-29 N020140-003 FUSILEV LEVOLEUCOVORIN CALCIUM EQ 250MG BASE/25ML (EQ 10MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** SOLUTION / INTRAVENOUS RLD 2011-04-29
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 4 · 129 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 N020140-001 FUSILEV EQ 50MG BASE/VIAL POWDER / INTRAVENOUS RLD 2008-03-07 84e616aacf4f…2026-09-14 22:38:34 2026-08 N020140-002 FUSILEV EQ 175MG BASE/17.5ML (EQ 10MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** SOLUTION / INTRAVENOUS RLD 2011-04-29 84e616aacf4f…2026-09-14 22:38:34 2026-08 N020140-003 FUSILEV EQ 250MG BASE/25ML (EQ 10MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** SOLUTION / INTRAVENOUS RLD 2011-04-29 84e616aacf4f…2026-08-18 06:07:40 2026-07 N020140-001 FUSILEV EQ 50MG BASE/VIAL POWDER / INTRAVENOUS RLD 2008-03-07 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N020140-002 FUSILEV EQ 175MG BASE/17.5ML (EQ 10MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** SOLUTION / INTRAVENOUS RLD 2011-04-29 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N020140-003 FUSILEV EQ 250MG BASE/25ML (EQ 10MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** SOLUTION / INTRAVENOUS RLD 2011-04-29 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N020140-001 FUSILEV EQ 50MG BASE/VIAL POWDER / INTRAVENOUS RLD 2008-03-07 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N020140-002 FUSILEV EQ 175MG BASE/17.5ML (EQ 10MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** SOLUTION / INTRAVENOUS RLD 2011-04-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N020140-003 FUSILEV EQ 250MG BASE/25ML (EQ 10MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** SOLUTION / INTRAVENOUS RLD 2011-04-29 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N020140-001 FUSILEV EQ 50MG BASE/VIAL POWDER / INTRAVENOUS RLD 2008-03-07 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N020140-002 FUSILEV EQ 175MG BASE/17.5ML (EQ 10MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** SOLUTION / INTRAVENOUS RLD 2011-04-29 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N020140-003 FUSILEV EQ 250MG BASE/25ML (EQ 10MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** SOLUTION / INTRAVENOUS RLD 2011-04-29 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N020140-001 FUSILEV EQ 50MG BASE/VIAL POWDER / INTRAVENOUS RLD 2008-03-07 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N020140-002 FUSILEV EQ 175MG BASE/17.5ML (EQ 10MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** SOLUTION / INTRAVENOUS RLD 2011-04-29 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N020140-003 FUSILEV EQ 250MG BASE/25ML (EQ 10MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** SOLUTION / INTRAVENOUS RLD 2011-04-29 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N020140-001 FUSILEV EQ 50MG BASE/VIAL POWDER / INTRAVENOUS RLD 2008-03-07 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N020140-002 FUSILEV EQ 175MG BASE/17.5ML (EQ 10MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** SOLUTION / INTRAVENOUS RLD 2011-04-29 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N020140-003 FUSILEV EQ 250MG BASE/25ML (EQ 10MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** SOLUTION / INTRAVENOUS RLD 2011-04-29 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N020140-001 FUSILEV EQ 50MG BASE/VIAL POWDER / INTRAVENOUS RLD 2008-03-07 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N020140-002 FUSILEV EQ 175MG BASE/17.5ML (EQ 10MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** SOLUTION / INTRAVENOUS RLD 2011-04-29 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N020140-003 FUSILEV EQ 250MG BASE/25ML (EQ 10MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** SOLUTION / INTRAVENOUS RLD 2011-04-29 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N020140-001 FUSILEV EQ 50MG BASE/VIAL POWDER / INTRAVENOUS RLD 2008-03-07 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N020140-002 FUSILEV EQ 175MG BASE/17.5ML (EQ 10MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** SOLUTION / INTRAVENOUS RLD 2011-04-29 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N020140-003 FUSILEV EQ 250MG BASE/25ML (EQ 10MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** SOLUTION / INTRAVENOUS RLD 2011-04-29 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N020140-001 FUSILEV EQ 50MG BASE/VIAL POWDER / INTRAVENOUS RLD 2008-03-07 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N020140-002 FUSILEV EQ 175MG BASE/17.5ML (EQ 10MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** SOLUTION / INTRAVENOUS RLD 2011-04-29 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N020140-003 FUSILEV EQ 250MG BASE/25ML (EQ 10MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** SOLUTION / INTRAVENOUS RLD 2011-04-29 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N020140-001 FUSILEV EQ 50MG BASE/VIAL POWDER / INTRAVENOUS RLD 2008-03-07 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N020140-002 FUSILEV EQ 175MG BASE/17.5ML (EQ 10MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** SOLUTION / INTRAVENOUS RLD 2011-04-29 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N020140-003 FUSILEV EQ 250MG BASE/25ML (EQ 10MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** SOLUTION / INTRAVENOUS RLD 2011-04-29 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N020140-001 FUSILEV EQ 50MG BASE/VIAL POWDER / INTRAVENOUS RLD 2008-03-07 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N020140-002 FUSILEV EQ 175MG BASE/17.5ML (EQ 10MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** SOLUTION / INTRAVENOUS RLD 2011-04-29 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N020140-003 FUSILEV EQ 250MG BASE/25ML (EQ 10MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** SOLUTION / INTRAVENOUS RLD 2011-04-29 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N020140-001 FUSILEV EQ 50MG BASE/VIAL POWDER / INTRAVENOUS RLD 2008-03-07 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N020140-002 FUSILEV EQ 175MG BASE/17.5ML (EQ 10MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** SOLUTION / INTRAVENOUS RLD 2011-04-29 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N020140-003 FUSILEV EQ 250MG BASE/25ML (EQ 10MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** SOLUTION / INTRAVENOUS RLD 2011-04-29 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N020140-001 FUSILEV EQ 50MG BASE/VIAL POWDER / INTRAVENOUS RLD 2008-03-07 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N020140-002 FUSILEV EQ 175MG BASE/17.5ML (EQ 10MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** SOLUTION / INTRAVENOUS RLD 2011-04-29 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N020140-003 FUSILEV EQ 250MG BASE/25ML (EQ 10MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** SOLUTION / INTRAVENOUS RLD 2011-04-29 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N020140-001 FUSILEV EQ 50MG BASE/VIAL POWDER / INTRAVENOUS RLD 2008-03-07 301d65b070ca…
Observed Orange Book normalized TE history# Observed Orange Book patent history# Patent history page 1 of 2 · 54 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N020140-001 6500829 2022-03-07 Drug substance, Drug product 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N020140-002 6500829 2022-03-07 Drug substance, Drug product 2011-05-09 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N020140-003 6500829 2022-03-07 Drug substance, Drug product 2011-05-09 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N020140-001 6500829 2022-03-07 Drug substance, Drug product 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N020140-002 6500829 2022-03-07 Drug substance, Drug product 2011-05-09 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N020140-003 6500829 2022-03-07 Drug substance, Drug product 2011-05-09 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N020140-001 6500829 2022-03-07 Drug substance, Drug product 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N020140-002 6500829 2022-03-07 Drug substance, Drug product 2011-05-09 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N020140-003 6500829 2022-03-07 Drug substance, Drug product 2011-05-09 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N020140-001 6500829 2022-03-07 Drug substance, Drug product 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N020140-002 6500829 2022-03-07 Drug substance, Drug product 2011-05-09 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N020140-003 6500829 2022-03-07 Drug substance, Drug product 2011-05-09 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N020140-001 6500829 2022-03-07 Drug substance, Drug product bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 N020140-002 6500829 2022-03-07 Drug substance, Drug product 2011-05-09 bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 N020140-003 6500829 2022-03-07 Drug substance, Drug product 2011-05-09 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N020140-001 6500829 2022-03-07 Drug substance, Drug product 782e0a99824c…2021-12-28 21:50 UTC 2021-12 N020140-002 6500829 2022-03-07 Drug substance, Drug product 2011-05-09 782e0a99824c…2021-12-28 21:50 UTC 2021-12 N020140-003 6500829 2022-03-07 Drug substance, Drug product 2011-05-09 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N020140-001 6500829 2022-03-07 Drug substance, Drug product 87673890dc5c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N020140-002 6500829 2022-03-07 Drug substance, Drug product 2011-05-09 87673890dc5c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N020140-003 6500829 2022-03-07 Drug substance, Drug product 2011-05-09 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N020140-001 6500829 2022-03-07 Drug substance, Drug product 5aa47cf7b7d7…2021-03-12 10:30 UTC 2021-03 N020140-002 6500829 2022-03-07 Drug substance, Drug product 2011-05-09 5aa47cf7b7d7…2021-03-12 10:30 UTC 2021-03 N020140-003 6500829 2022-03-07 Drug substance, Drug product 2011-05-09 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N020140-001 6500829 2022-03-07 Drug substance, Drug product 8869cabd3fbd…2020-12-22 03:56 UTC 2020-12 N020140-002 6500829 2022-03-07 Drug substance, Drug product 2011-05-09 8869cabd3fbd…2020-12-22 03:56 UTC 2020-12 N020140-003 6500829 2022-03-07 Drug substance, Drug product 2011-05-09 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N020140-001 6500829 2022-03-07 Drug substance, Drug product c0c555d07b60…2020-11-12 02:37 UTC 2020-11 N020140-002 6500829 2022-03-07 Drug substance, Drug product 2011-05-09 c0c555d07b60…2020-11-12 02:37 UTC 2020-11 N020140-003 6500829 2022-03-07 Drug substance, Drug product 2011-05-09 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 N020140-001 6500829 2022-03-07 Drug substance, Drug product 3f01610625f2…2019-12-14 00:12 UTC 2019-12 N020140-002 6500829 2022-03-07 Drug substance, Drug product 2011-05-09 3f01610625f2…2019-12-14 00:12 UTC 2019-12 N020140-003 6500829 2022-03-07 Drug substance, Drug product 2011-05-09 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N020140-001 6500829 2022-03-07 Drug substance, Drug product b00525d2431f…2019-09-15 20:21 UTC 2019-09 N020140-002 6500829 2022-03-07 Drug substance, Drug product 2011-05-09 b00525d2431f…2019-09-15 20:21 UTC 2019-09 N020140-003 6500829 2022-03-07 Drug substance, Drug product 2011-05-09 b00525d2431f…2019-07-19 19:46 UTC 2019-07 N020140-001 6500829 2022-03-07 Drug substance, Drug product ea99ee380514…2019-07-19 19:46 UTC 2019-07 N020140-002 6500829 2022-03-07 Drug substance, Drug product 2011-05-09 ea99ee380514…2019-07-19 19:46 UTC 2019-07 N020140-003 6500829 2022-03-07 Drug substance, Drug product 2011-05-09 ea99ee380514…2023-01-26 05:58 UTC 2023-01 N020140-001 6500829 2022-03-07 Drug substance, Drug product 3bdfa0b2c4d7…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded LEVOLEUCOVORIN CALCIUM ACTIVE INGREDIENT 778XL6VBS8 FUSILEV (LEVOLEUCOVORIN) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION FUSILEV (LEVOLEUCOVORIN) INJECTION, SOLUTION [SPECTRUM PHARMACEUTICALS, INC.] 6 LEVOLEUCOVORIN ACTIVE MOIETY 990S25980Y FUSILEV (LEVOLEUCOVORIN) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION FUSILEV (LEVOLEUCOVORIN) INJECTION, SOLUTION [SPECTRUM PHARMACEUTICALS, INC.] 6 HYDROCHLORIC ACID INACTIVE INGREDIENT QTT17582CB FUSILEV (LEVOLEUCOVORIN) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION FUSILEV (LEVOLEUCOVORIN) INJECTION, SOLUTION [SPECTRUM PHARMACEUTICALS, INC.] 6 MANNITOL INACTIVE INGREDIENT 3OWL53L36A FUSILEV (LEVOLEUCOVORIN) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION FUSILEV (LEVOLEUCOVORIN) INJECTION, SOLUTION [SPECTRUM PHARMACEUTICALS, INC.] 6 SODIUM CHLORIDE INACTIVE INGREDIENT 451W47IQ8X FUSILEV (LEVOLEUCOVORIN) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION FUSILEV (LEVOLEUCOVORIN) INJECTION, SOLUTION [SPECTRUM PHARMACEUTICALS, INC.] 6 SODIUM HYDROXIDE INACTIVE INGREDIENT 55X04QC32I FUSILEV (LEVOLEUCOVORIN) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION FUSILEV (LEVOLEUCOVORIN) INJECTION, SOLUTION [SPECTRUM PHARMACEUTICALS, INC.] 6 WATER INACTIVE INGREDIENT 059QF0KO0R FUSILEV (LEVOLEUCOVORIN) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION FUSILEV (LEVOLEUCOVORIN) INJECTION, SOLUTION [SPECTRUM PHARMACEUTICALS, INC.] 6